Cancer Drugs: Strategies For Patenting Antibody-Drug Conjugate Inventions
JD Supra Law
APRIL 30, 2024
Food and Drug Administration (FDA) approval and rapidly growing market size as discussed in previous articles in this series. This article discusses patent strategies for ADC inventions. Antibody-drug conjugate (ADC) is a promising class of cancer treatments with accelerating U.S. By: Foley & Lardner LLP
Let's personalize your content